| Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms KV Argyropoulos, A Serrano, J Hu, M Black, X Feng, G Shen, M Call, ... The American journal of pathology 190 (9), 1881-1887, 2020 | 195 | 2020 |
| Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region MT Maurano, S Ramaswami, P Zappile, D Dimartino, L Boytard, ... Genome research 30 (12), 1781-1788, 2020 | 77 | 2020 |
| Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database M Dimitrova, MJ Kim, I Osman, G Jour Cancer Reports 4 (4), e1380, 2021 | 1 | 2021 |
| Lack of evidence to support large-panel genomic testing in treatment selection for malignant melanoma. M Dimitrova, MJ Kim, DM Donnelly, KM Giles, U Moran, JS Weber, ... Journal of Clinical Oncology 38 (15_suppl), e22027-e22027, 2020 | 1 | 2020 |
| Genome-wide association study to reveal novel germline markers of melanoma survival. V Chat, R Ferguson, L Morales, U Moran, MJ Kim, M Snuderl, I Osman, ... Journal of Clinical Oncology 39 (15_suppl), 9581-9581, 2021 | | 2021 |
| The risk and tropism of central nervous system metastases (CNS) in patients with stage II cutaneous melanoma. P Johannet, MJ Kim, M Call, N Gulati, J Zhong, JM Mehnert, I Osman Journal of Clinical Oncology 39 (15_suppl), 9551-9551, 2021 | | 2021 |
| Association of pre-existing autoimmune diseases in melanoma patients receiving immune checkpoint inhibition with improved survival and increased toxicity. N Gulati, A Celen, P Johannet, A Sawyers, MJ Kim, JM Mehnert, ... Journal of Clinical Oncology 39 (15_suppl), e21586-e21586, 2021 | | 2021 |
